Destiny Pharma announces publication of XF-73 nasal gel Phase 2 data in leading US journal Infection Control & Hospital Epidemiology

Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business

InflaRx reports full year 2022 financial and operating results

A new prestigious scientific publication for Carbios marks the expansion of its research to other plastics

Mainz Biomed to present at Sidoti Virtual Investor Conference March 22-23

Rentschler Biopharma’s service excellence recognized with CDMO Leadership Awards and Champion status

Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia

Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure

Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany

ONWARD to publish full year 2022 financial results and host webcast on March 28, 2023